Stocks · Technology · Laboratory Analytical Instruments

Nautilus Biotechnology, Inc.

NAUT Clue Score32
United States Fiscal year ends December CIK 0001808805 Results filed 27 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
AH Equity Partners Bio II, L.L.C.
2 Jun 2026
10% owner
Sell indirect
384,026
$2.35
$902.46K
AH Equity Partners Bio II, L.L.C.
2 Jun 2026
10% owner
Sell indirect
4,615,974
$2.35
$10.85M
Sujal M Patel
4 Mar 2026
CEO, President, and Secretary
Buy
25,000
$2.61
$65.24K
Kentaro Suzuki
6 Nov 2025
Chief Marketing Officer
Buy
4,000
$1.49
$5.96K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 0
History held since 11 Aug 2020